Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ExoDx Prostate Evaluation in Active Surveillance Patient Population

NCT05572099 is registered in ClinicalTrials.gov with Exosome Diagnostics, Inc. as lead sponsor.

NCT NCT05572099
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05572099 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ExoDx Prostate Evaluation in Active Surveillance Patient Population
Lead sponsor
Exosome Diagnostics, Inc.
Phase
Observational
Overall status
Unknown status
Start date
October 1, 2022
Completion date
October 31, 2023
Enrollment
750 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer